ADGRD1 and neoplasm: Magnetic resonance imaging (MRI) and volumetric tumor analyses with the AMIRA software 1 month after injection revealed that control cells were able to form large tumors, as opposed to GPR133-KD no. 1 cells, which showed impaired tumor formation (Figures 6a and b).